Media

Oncopeptides publishes two articles with results from ANCHOR and LIGHTHOUSE studies in Haematologica

Oncorena’s First Patient Treated with ONC175 (orellanine) in clinial phase I/II trial  in Patients with Metastatic Renal Cancer and Dialysis at Karolinska University Hospital in Stockholm, Sweden

Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit

Tribune Therapeutics announces new CMC collaboration

Information regarding Oncopeptides’ appeal of U.S. withdrawal published

Aprea Therapeutics Appoints Dr. Jean-Pierre Bizzari to its Board of Directors and Names Dr. Richard Peters as Chairman

Vicore Pharma Holding AB: Interim report April-June 2023

Vicore reports data from EndoPAT® exploratory trial

Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates

Aprea Therapeutics Reports Second Quarter 2023 Financial Results and Provides Update on Business Operations